855 results on '"Kunos, George"'
Search Results
202. The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System
203. The role of the endocannabinoid system in cirrhotic cardiomyopathy
204. Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver
205. Role of CB2 cannabinoid receptors in interplay between endothelium and inflammatory cells: implications for ischemia‐reperfusion injury and atherosclerosis.
206. Cannabinoid receptor‐1 deletion or inhibition protects against doxorubicin‐induced cardiotoxicity.
207. Endocannabinoids, CB1 Receptors, and Liver Disease: Hitting More Than One Bird With the Same Stone
208. AMP‐activated protein kinase mediates glucocorticoid‐ induced metabolic changes: a novel mechanism in Cushing's syndrome
209. Endocannabinoids acting at CB1receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats
210. Cannabinoid Modulation of Kaposi's Sarcoma–Associated Herpesvirus Infection and Transformation
211. Inhibition of human hair follicle growth by endo‐and exocannabinoids
212. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
213. The endocannabinoid 2‐arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species
214. Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury
215. Endogenous Cannabinoid-Like Arachidonoyl Serine Protects Against LPS-Induced Endothelial Apoptosis.
216. Delta (9)-Tetrahydrocannabinol Contributes to the Development of Kaposi’s Sarcoma.
217. The Endocannabinoid System as an Emerging Target of Pharmacotherapy
218. Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference
219. N -arachidonoyl l -serine, an endocannabinoid-like brain constituent with vasodilatory properties
220. Low doses of alcohol substantially decrease glucose metabolism in the human brain
221. Overview of Nonclassical Cannabinoid Receptors.
222. Endogenous Cannabinoid-Like Arachidonoyl Serine Induces Angiogenesis through Novel Pathways.
223. The Potential Role of Delta(9)-Tetrahydrocannabinol in the Pathogenesis of Kaposi’s Sarcoma.
224. Cirrhotic cardiomyopathy: an endocannabinoid connection?
225. Coronary Vasodilator Effects of Endogenous Cannabinoids in Vasopressin-Preconstricted Unpaced Rat Isolated Hearts
226. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase
227. Blood pressure regulation by endocannabinoids and their receptors
228. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
229. Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide
230. Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
231. Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors
232. Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock‐out mice
233. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1
234. Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor
235. G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current
236. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats1 1The authors thank Tim Lee (Moor Instruments Ltd., Millwey, United Kingdom) for assistance with Laser Doppler Image analysis.
237. Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
238. Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
239. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice
240. The quest for a vascular endothelial cannabinoid receptor
241. Dose-dependent Activation of Antiapoptotic and Proapoptotic Pathways by Ethanol Treatment in Human Vascular Endothelial Cells
242. Ethanol, Endocannabinoids, and the Cannabinoidergic Signaling System
243. CB 1 Receptor Antagonist SR141716A Inhibits Ca 2+ -Induced Relaxation in CB 1 Receptor-Deficient Mice
244. Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus
245. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors
246. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
247. Leptin-regulated endocannabinoids are involved in maintaining food intake
248. Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids
249. Southwestern Blots for Detection of a DNA Binding Protein Recognizing the α1B-Adrenergic Receptor Gene Promoter.
250. DNase I Footprinting Analysis of Transcription Factors Recognizing Adrenergic Receptor Gene Promoter Sequences.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.